Home >  News >  March, 2014

FDA Recalls McKesson's Anesthesia Software

See why concerns about medication safety prompted the warning.

Published: March 21, 2014

The FDA has issued a Class I recall of McKesson's Anesthesia Care, a web-based data management system that captures patient information for quick reference during surgery.

According to the recall, the software switched one patient's data for another, a potentially devastating mishap considering providers rely on the system to relay alerts about medication contraindications.

McKesson first contacted affected customers about the issue with e-mails and phone calls in March 2013, but the FDA apparently still felt compelled to act.

"There was no patient impact, and there was only one customer report associated with this issue for a single patient record," says Kris Fortner, director of corporate marketing and public relations for McKesson. "We kept the FDA apprised monthly, and have been closely monitoring product performance."

Mr. Fortner says the company is working with the FDA to close the recall.

The company's customers can call 800-442-6767 (option 3) or 404-338-3556 for more information.

Daniel Cook

Also in the News...

One Small Incision in the Navel Is All That's Needed With New Lap Chole System
At ORX, a Tragedy Recounted Underscores The Urgency of Eliminating Medical Errors
ORX Attendees Learn How to Add Outpatient Total Joints
At ORX, an Expert Recipe for Improved Patient Safety
ORX Panel: Why You Should Post Your Prices Online
Study Finds Significant Savings With Outpatient Total Ankles
Tech Triumphs in Lawsuit Over Years of Unwanted Advances

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

News & Notes

Federal Budget Takes Aim at Hospital-Owned Surgery Centers

"Site-neutral" provision applies to facilities acquired after 2016.

FDA Reclassifies Vaginal Mesh as High-Risk Device and Orders Manufacturers to Address Safety Concerns

The move is the latest effort to improve the safety of transvaginal pelvic organ prolapse procedures.